Garry J. Douglas
Allschwil, BL, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Direct Airway Instillation of Neutrophils Overcomes Chemotactic Deficits Induced by Injury.
Journal: Shock (Augusta, Ga.)
Published: November 12, 2020
Formyl Peptide Receptor-1 Blockade Prevents Receptor Regulation by Mitochondrial Danger-Associated Molecular Patterns and Preserves Neutrophil Function After Trauma.
Journal: Critical care medicine
Published: January 16, 2020
Multifaceted C-X-C Chemokine Receptor 4 (CXCR4) Inhibition Interferes with Anti-Vascular Endothelial Growth Factor Therapy-Induced Glioma Dissemination.
Journal: The American journal of pathology
Published: March 03, 2017
Mobilization of hematopoietic stem cells with the novel CXCR4 antagonist POL6326 (balixafortide) in healthy volunteers-results of a dose escalation trial.
Journal: Journal of translational medicine
Published: October 10, 2016
POL7085 or anti-CCL28 treatment inhibits development of post-paramyxoviral airway disease.
Journal: Immunity, inflammation and disease
Published: September 19, 2016
CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer.
Journal: Molecular cancer therapeutics
Published: March 30, 2015
Protective effect of a Protein Epitope Mimetic CCR10 antagonist, POL7085, in a model of allergic eosinophilic airway inflammation.
Journal: Respiratory research
Published: January 08, 2015
Combined VEGF and CXCR4 antagonism targets the GBM stem cell population and synergistically improves survival in an intracranial mouse model of glioblastoma.
Journal: Oncotarget
Published: September 20, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026